Drug Profile
Nuclomedone - Beijing Tide Pharmaceutical
Alternative Names: DRP-043; NSL 043; SD-118; TEI 3096; TI 31Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Teijin
- Developer Beijing Tide Pharmaceutical; Teijin
- Class Antirheumatics; Small molecules; Thiazoles
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
- Discontinued Rheumatic disorders